ATE285770T1 - Verfahren zur herstellung von carbapenem- antibiotika zubereitungen - Google Patents
Verfahren zur herstellung von carbapenem- antibiotika zubereitungenInfo
- Publication number
- ATE285770T1 ATE285770T1 AT00974020T AT00974020T ATE285770T1 AT E285770 T1 ATE285770 T1 AT E285770T1 AT 00974020 T AT00974020 T AT 00974020T AT 00974020 T AT00974020 T AT 00974020T AT E285770 T1 ATE285770 T1 AT E285770T1
- Authority
- AT
- Austria
- Prior art keywords
- carbapenem
- carbapenem antibiotic
- antibiotic preparations
- producing carbapenem
- formulation
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 2
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- PLQZQEVQLGHUET-NUBCRITNSA-N C1C=CN2[C@H]1CC2=O.[Na] Chemical compound C1C=CN2[C@H]1CC2=O.[Na] PLQZQEVQLGHUET-NUBCRITNSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16248299P | 1999-10-29 | 1999-10-29 | |
| PCT/US2000/029869 WO2001032172A1 (en) | 1999-10-29 | 2000-10-27 | Process for formulation of carbapenem antibiotic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE285770T1 true ATE285770T1 (de) | 2005-01-15 |
Family
ID=22585803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00974020T ATE285770T1 (de) | 1999-10-29 | 2000-10-27 | Verfahren zur herstellung von carbapenem- antibiotika zubereitungen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1244444B1 (de) |
| JP (1) | JP4854899B2 (de) |
| AT (1) | ATE285770T1 (de) |
| AU (1) | AU770165B2 (de) |
| CA (1) | CA2388163C (de) |
| DE (1) | DE60017194T2 (de) |
| ES (1) | ES2234689T3 (de) |
| WO (1) | WO2001032172A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548492B1 (en) * | 1999-10-29 | 2003-04-15 | Merck & Co., Inc. | Process for formulation of carbapenem antibiotic compositions |
| EP1469886B8 (de) * | 2002-02-01 | 2008-01-09 | Shimoda Biotech (PTY) LTD | Lyophilisierte pharmazeutische zusammensetzung von propofol |
| EP2303225B1 (de) * | 2008-06-11 | 2013-11-20 | Ranbaxy Laboratories Limited | Zusammensetzungen des Kohlenstoffdioxid Adduktes von Ertapenem und Polymorphe Formen des Mononatriumsalzes von Ertapenem |
| US8691803B2 (en) * | 2011-01-24 | 2014-04-08 | Savior Lifetec Corporation | Process for the preparation of antibiotic compounds |
| CA2910421A1 (en) * | 2013-05-07 | 2014-11-13 | Mcmaster University | Inhibitors of metallo-.beta.-lactamase-enzymes |
| KR101587420B1 (ko) * | 2014-08-20 | 2016-01-22 | 주식회사 대웅제약 | 에르타페넴-함유 동결건조제제의 제조방법 |
| KR20170014842A (ko) | 2015-07-31 | 2017-02-08 | 주식회사 대웅제약 | 개선된 에르타페넴 주사제의 제조방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP970281B1 (en) * | 1996-05-28 | 2002-04-30 | Merck & Co Inc | Carbapenem antibiotic, composition and method of preparation |
| UA62920C2 (en) * | 1996-05-28 | 2004-01-15 | Merck & Co Inc | Carbapeneme antibiotic, a composition and a method for the preparation |
| AU725298B2 (en) * | 1996-10-28 | 2000-10-12 | Merck & Co., Inc. | Stabilized carbapenem antibiotic compositions and method of making |
| US6297231B1 (en) * | 1996-10-28 | 2001-10-02 | Merck & Co., Inc. | Stabilized carbapenem antibiotic compositions and method of making |
| JP3245427B2 (ja) * | 1997-06-16 | 2002-01-15 | メルク エンド カンパニー インコーポレーテッド | 安定化されたカルバペネム中間体および合成における使用 |
-
2000
- 2000-10-27 CA CA002388163A patent/CA2388163C/en not_active Expired - Lifetime
- 2000-10-27 AT AT00974020T patent/ATE285770T1/de not_active IP Right Cessation
- 2000-10-27 AU AU12456/01A patent/AU770165B2/en not_active Expired
- 2000-10-27 JP JP2001534377A patent/JP4854899B2/ja not_active Expired - Lifetime
- 2000-10-27 DE DE60017194T patent/DE60017194T2/de not_active Expired - Lifetime
- 2000-10-27 ES ES00974020T patent/ES2234689T3/es not_active Expired - Lifetime
- 2000-10-27 WO PCT/US2000/029869 patent/WO2001032172A1/en not_active Ceased
- 2000-10-27 EP EP00974020A patent/EP1244444B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60017194D1 (de) | 2005-02-03 |
| JP4854899B2 (ja) | 2012-01-18 |
| EP1244444A4 (de) | 2003-05-21 |
| EP1244444A1 (de) | 2002-10-02 |
| CA2388163C (en) | 2009-08-25 |
| AU1245601A (en) | 2001-05-14 |
| CA2388163A1 (en) | 2001-05-10 |
| DE60017194T2 (de) | 2005-12-22 |
| EP1244444B1 (de) | 2004-12-29 |
| AU770165B2 (en) | 2004-02-12 |
| ES2234689T3 (es) | 2005-07-01 |
| WO2001032172A1 (en) | 2001-05-10 |
| JP2003514779A (ja) | 2003-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE378341T1 (de) | Verfahren zur formulierung antibiotischer verbindungen | |
| BR0207294A (pt) | Composto, processo para a preparação de um composto ou de um sal farmaceuticamente aceitável ou um éster hidrolisável in vivo dos mesmos, composição farmacêutica, uso de um composto ou de um sal farmaceuticamente aceitável ou um éster hidrolisável in vivo dos mesmos, e, método para a produção de um efeito inibitório do ciclo celular (antiproliferação celular) em um animal de sangue quente | |
| HUT45247A (en) | Process for producing thiazolidinediones with hypolycaemic effect and pharmaceutical compositions comprising the same | |
| CA2030433A1 (en) | New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases | |
| HU9201258D0 (en) | Process for the production of medical preparations for treating hiv infections and of their active agents | |
| HUT67039A (en) | Process for preparing 2-substituted saccharin derivatives and pharmaceutical compositions containing them | |
| FI951468A0 (fi) | Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| KR910015562A (ko) | 뇌부전 질환치료용 약제, 신규 2-(1-피페라지닐)-4-페닐시클로알카노 피리미딘 유도체, 및 그의 제법 | |
| ATE223916T1 (de) | Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung | |
| FI882605A0 (fi) | Menetelmä, jonka avulla voidaan valmistaa suuren spesifisen tilavuusaktiivisuuden omaavaa liuosta proteiinista, jolla on kudosplasminogeeniaktivaattori(t-PA)-aktiivisuutta | |
| DE60017194D1 (de) | Verfahren zur herstellung von carbapenem-antibiotika zubereitungen | |
| CA1214102A (en) | Pharmaceutical preparation containing purified fibronectin | |
| DE69501359D1 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
| ATE100210T1 (de) | Lyophilisiertes mdm enthaltende zusammensetzung und verfahren zu deren herstellung. | |
| FI96424B (fi) | Menetelmä kiteisten kefeemihappoadditiosuolojen valmistamiseksi | |
| HUT46212A (en) | Process for production of antibacterial liofilized compounds | |
| DE60127948D1 (de) | Verfahren zur herstellung von avermectinderivaten | |
| EP0153710A2 (de) | Aus Pseudomonas aeruginosa stammende Elastase-Toxoide | |
| ATE137971T1 (de) | Verfahren zum herstellen von arzneizusammensetzungen, die vecuroniumbromid enthalten | |
| ATE335494T1 (de) | Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen | |
| WO2002060475A1 (en) | Methods for stabilizing lyophilized blood proteins | |
| DE69429447D1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen | |
| RU94031260A (ru) | Питательная среда для выделения и культивирования гонококка | |
| ATE210985T1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen | |
| KR900014405A (ko) | 세팔로스포린 유도체 및 이의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |